The anticonvulsant topiramate (multiple brands), combined with psychosocial therapy, reduced cannabis use in dependent individuals, new research shows. However, the study also revealed that the drug ...
Another possible risk factor for the development of topiramate-related cognitive side effects may be genetic predisposition. In the current paper, Cirulli and colleagues administered 100 mg of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback